TAK-186
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-186, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer [Phase 1, Phase 2]